Академический Документы
Профессиональный Документы
Культура Документы
css
Pradeep Unnikrishnan DOB: 11/02/1985 Age: 33Y Adobe Systems India Private
Gender: M Limited
7259035947 PID: 683853234 Bangalore Trinity Bangalore ,
Bangalore, Karnataka 560029
Physician: Phone:
Order# Collected Date/Time Reported Date/Time Status
1000325603 16/05/2018 12:30 20/05/2018 02:05 Final Report
PM PM
Order Comments
CREATININE W/EGFR
Within Out of
Test Biological Ref Range Units
Range Range
CREATININE 1.13 0.50 - 1.40 mg/dL
METHOD : JAFFE'S
KINETIC
SAMPLE TYPE : SERUM
GFR ESTIMATED 85 >73 mL/min/1.73m2
**Panel Comments**
CREATININE W/EGFR
GFR is usually accepted as the best overall index of kidney function in health and
disease. Normal GFR varies according to age, sex and body size. In young adults it is
approximately 120-130 ml/min/1.73 m sq and declines with age. A decrease in GFR
precedes the onset of kidney failure; therefore a persistently reduced GFR is a
specific indication of CKD. Below 60 ml/min/1.73 m sq , the prevalence of
complications of CKD increases.
Chronic Kidney Disease - Epidemiology Collaboration (CKD-EPI) is a new equation to
estimate glomerular filtration
ra
te.The CKD-EPI equation more appropriately
categorizes individuals with respect to long-term clinical risk compared with the
MDRD Study equation, suggesting improved clinical usefulness in middle-aged
population. A key advantage of CKD-EPI is that there is no upper limit for reporting
eGFR as there is with the MDRD Study equation. The e GFR calculation is valid for
Asians and Caucasions. For people of Africans descent please contact us for modified
eGFR values.
AUTOMATED CHEMISTRY
Within Out of Biological Ref
Test Units
Range Range Range
ALKALINE PHOSPHATASE 48 40 - 115 U/L
METHOD : IFCC/PNPP
SAMPLE TYPE :
SERUM
BILIRUBIN, DIRECT 0.1 < 0.4 mg/dL
METHOD : DIAZO
SAMPLE TYPE :
SERUM
BILIRUBIN, TOTAL 0.6 0.2 - 1.2 mg/dL
METHOD : DIAZO
SAMPLE TYPE :
SERUM
UREA NITROGEN (BUN) 13 7 - 25 mg/dL
METHOD :
UREASE/GLDH
SAMPLE TYPE : SERUM
CHOLESTEROL, TOTAL 300 H < 200 mg/dL
METHOD : CHOD-POD
SAMPLE TYPE :
SERUM
GAMMA GLUTAMYL 36 < 65 U/L
TRANSFERASE
METHOD : G-GLUT-3-CARBOXY-4
NITRO
SAMPLE TYPE : SERUM
ALANINE AMINOTRANSFERASE 50 H 9 - 46 U/L
(ALT/SGPT)
METHOD : IFCC WITH
NAD
SAMPLE TYPE : SERUM
URIC ACID 6.6 4.4 - 7.6 mg/dL
METHOD : URICASE
SAMPLE TYPE :
SERUM
SPECIAL CHEMISTRY
Within Out of Biological Ref
Test Units
Range Range Range
VITAMIN B12 189 L 200 - 1100 pg/mL
METHOD :
CHEMILUMINESCENCE
SAMPLE TYPE : SERUM
25 HYDROXY VITAMIN D- 8.9 L 30.0 - 100.0 ng/mL
TOTAL
METHOD : CHEMILUMINESCENCE IMMUNOASSAY
Deficiency : < 20 ng/mL
Insufficiency : 20-30 ng/mL
Sufficiency : 30-100 ng/mL
Toxicity : > 100 ng/mL
This test measures total Vitamin D (25-OH Vitamin D). In
the
body Vitamin D occurs in two forms: Vitamin D3
(endogenous, animal origin, cholecalciferol) and Vitamin
D2
(exogenous, plant origin, ergocalciferol).
25-OH Vitamin D is a precursor of the active form (1,25
Di-hydroxy Vitamin D) and levels are used to diagnose
either
vitamin D deficiency or excess, which may cause weakness,
bone malformation, or abnormal metabolism of calcium.
There
is increasing evidence that Vitamin D deficiency may
increase the risk of some cancers, diabetes, immune
disorders, and cardiovascular disease. High levels of 25-
OH
Vitamin D usually reflect excess supplementation.
Therapy is based on measurement of Total 25-OH Vitamin D,
with levels <20 ng/mL indicative of Vitamin D deficiency,
whereas levels between 30 ng/mL to 100 ng/mL are
considered
normal.
___________________________________________________
end of report for Pradeep Unnikrishnan, Order No #1000325603, Acc No # 180559097 180559093
180559095 180559096 180559092 180559094 180559098 180559091
2777932- Autolims Version All Rights
12226071 3.02 On 25/05/2018 Reserved